In early 2026, the UK has introduced a legal mandate requiring all clinical trials to register in a public registry and share their results within 12 months of completion. This 2026 transparency initiative is a key part of the regulatory overhaul, intended to build public trust by ensuring that the outcomes of all research—whether positive or negative—are accessible to patients and...